Recombinant Human TAF15 Protein，His

TAF15 (Tat-interactive protein 15) is a member of the FUS/TLS family of RNA-binding proteins, playing crucial roles in diverse cellular processes such as transcription regulation, RNA processing, and stress response. It has garnered significant attention in recent years due to its involvement in various neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where pathological aggregation of TAF15 is observed. Research has highlighted the significance of TAF15’s RNA-binding capabilities and its capacity to modulate gene expression by interacting with specific RNA sequences. The study of recombinant TAF15 proteins allows scientists to elucidate the structure-function relationship of this protein and the mechanisms underlying its aggregation in disease states. Furthermore, understanding the dynamics of TAF15 in different cellular environments can help identify potential therapeutic targets for the aforementioned conditions. Given the growing evidence linking TAF15 dysregulation to neurodegeneration, ongoing research aims to characterize its conformational states, binding interactions, and post-translational modifications, paving the way for developing interventions that may alleviate or counteract the detrimental effects associated with TAF15 aggregation. This includes exploring its role in cellular stress responses and how its dysfunction might contribute to pathological processes, thereby broadening our understanding of the molecular underpinnings of neurodegenerative diseases. Overall, TAF15 serves as an important model for studying RNA-binding proteins and their implications in health and disease.